id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-2004-0004,FDA,FDA-2026-P-2004,Attachment 2,Supporting & Related Material,Background Material,2026-02-25T05:00:00Z,2026,2,,,2026-02-25T23:22:03Z,,0,0,09000064b91dab5d
FDA-2026-P-2004-0002,FDA,FDA-2026-P-2004,Acknowledgement Letter from FDA DMB to Felix Pharmaceuticals Pvt. Ltd,Other,Acknowledgement Letter/Receipt,2026-02-25T05:00:00Z,2026,2,2026-02-25T05:00:00Z,,2026-02-25T23:21:54Z,,0,0,09000064b91dab68
FDA-2026-P-2004-0001,FDA,FDA-2026-P-2004,Suitability Petition from Felix Pharmaceuticals Pvt. Ltd,Other,Petition(s),2026-02-25T05:00:00Z,2026,2,2026-02-25T05:00:00Z,,2026-02-25T23:21:49Z,,1,0,09000064b91dab66
FDA-2026-P-2004-0005,FDA,FDA-2026-P-2004,Attachment 3,Supporting & Related Material,Background Material,2026-02-25T05:00:00Z,2026,2,,,2026-02-25T23:22:06Z,,0,0,09000064b91dab5e
FDA-2026-P-2004-0003,FDA,FDA-2026-P-2004,Attachment 1,Supporting & Related Material,Background Material,2026-02-25T05:00:00Z,2026,2,,,2026-02-25T23:22:01Z,,0,0,09000064b91dab5c